Cantel Medical Corp. (CMD): Price and Financial Metrics


Cantel Medical Corp. (CMD)

Today's Latest Price: $47.77 USD

1.62 (3.51%)

Updated Jun 4 6:40pm

Add CMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

CMD Stock Summary

  • CMD's current price/earnings ratio is 98.18, which is higher than 94.24% of US stocks with positive earnings.
  • With a year-over-year growth in debt of 307.65%, Cantel Medical Corp's debt growth rate surpasses 94.59% of about US stocks.
  • Cantel Medical Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.68%, greater than the shareholder yield of only 12.22% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Cantel Medical Corp, a group of peers worth examining would be CNMD, GCP, INGN, KAI, and CSTE.
  • Visit CMD's SEC page to see the company's official filings. To visit the company's web site, go to www.cantelmedical.com.
CMD Daily Price Range
CMD 52-Week Price Range

CMD Stock Price Chart More Charts


CMD Price/Volume Stats

Current price $47.77 52-week high $93.87
Prev. close $46.15 52-week low $20.81
Day low $44.21 Volume 1,453,300
Day high $49.55 Avg. volume 697,626
50-day MA $34.74 Dividend yield 0.44%
200-day MA $60.99 Market Cap 2.03B

Cantel Medical Corp. (CMD) Company Bio


Cantel Medical Corporation provides infection prevention and control products and services in the healthcare market. The company operates in 5 segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Specialty Packaging. The company was founded in 1963 and is based in Little Falls, New Jersey.

CMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$47.77$3.03-93%

Below please find a table outlining a discounted cash flow forecast for CMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cantel Medical Corp ranked in the 10th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 93.17%. The most interesting components of our discounted cash flow analysis for Cantel Medical Corp ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 67. Notably, its equity weight is greater than just 20.12% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Its compound free cash flow growth rate, as measured over the past 5.44 years, is -0.11% -- higher than only 16.09% of stocks in our DCF forecasting set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-94%
1%-93%
2%-93%
3%-93%
4%-93%
5%-93%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CMD, try SRDX, CRY, EHC, LCTC, and LHCG.


CMD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CMD Latest Social Stream


Loading social stream, please wait...

View Full CMD Social Stream

Latest CMD News From Around the Web

Below are the latest news stories about Cantel Medical Corp that investors may wish to consider to help them evaluate CMD as an investment opportunity.

Cantel Medical EPS misses by $0.03, beats on revenue

Cantel Medical (CMD): Q3 Non-GAAP EPS of $0.16 misses by $0.03; GAAP EPS of $0.37 beats by $0.36.Revenue of $236.93M (+3.6% Y/Y) beats by $1.52M.Press Release...

Seeking Alpha | June 4, 2020

Cantel Medical Corp (CMD) Q3 2020 Earnings Call Transcript

CMD earnings call for the period ending April 30, 2020.

Yahoo | June 4, 2020

Cantel Medical (CMD) Q3 Earnings and Revenues Surpass Estimates

Cantel (CMD) delivered earnings and revenue surprises of 14.29% and 0.54%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | June 4, 2020

Cantel Medical: Q3 Earnings Insights

Shares of Cantel Medical (NYSE:CMD) were flat in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share decreased 70.91% over the past year to $0.16, which missed the estimate of $0.37.Revenue of $236,933,000 rose by 3.67% from the same period last year, which missed the estimate of $242,630,000.Outlook Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.Details Of The Call Date: Jun 04, 2020View more earnings on CMDTime: 08:30 AMET Webcast URL: https://www.webcaster4.com/Webcast/Page/2203/34733Technicals 52-week high: $93.8752-week low: $20.81Price action over last quarter: down 16.65%Company Overview Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infect...

Yahoo | June 4, 2020

Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2020

Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2020.

Yahoo | June 4, 2020

Read More 'CMD' Stories Here

CMD Price Returns

1-mo 47.17%
3-mo -15.29%
6-mo -38.43%
1-year -36.55%
3-year -39.20%
5-year 2.02%
YTD -32.51%
2019 -4.53%
2018 -27.51%
2017 30.87%
2016 26.97%
2015 43.94%

CMD Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full CMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8444 seconds.